FDA to create medical device surveillance program

The FDA is building a postmarket surveillance program for medical devices.

Advertisement

The agency will look for medical device-related safety issues reported in EHRs, billing claims and pharmacy data, according to a U.S. Government Accountability Office report released Aug. 15.

The program will begin surveillance of two medical devices by December, with plans to increase the number of devices under investigation each year over the next five years. 

There were more than 1.7 million injuries and 83,000 deaths linked to medical device safety issues over a 10-year period, according to FDA data from 2018, the report said.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.